The development of the undertaking of EXIM by promotion on international markets. (Q83281): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): Reference_reference_programme_aids:SA.42799 (2015/X): _aid_public: _Article 19 The project will be implemented under BPP BIOTECHNOLOGY AND pharmaceuticatics for the prospective market:INDIA AND ZEA.The activities will be carried out in the UAE, India and SWITZERLAND within the scope of the project. promotional activities will be implemented through the purchase of an advice service on the internationalisation of entrepreneurs, training on the in...) |
||
| Property / summary | |||
Reference_reference_programme_aids:SA.42799 (2015/X): _aid_public: _Article 19 The project will be implemented under BPP BIOTECHNOLOGY AND pharmaceuticatics for the prospective market:INDIA AND ZEA.The activities will be carried out in the UAE, India and SWITZERLAND within the scope of the project. promotional activities will be implemented through the purchase of an advice service on the internationalisation of entrepreneurs, training on the internationalisation of entrepreneurs, staff missions at fairs and missions.The applicant will implement the project by booking exhibition spaces at trade fairs, making registration fees and registration fees in the market catalogue, organising exhibition stands at fairs and carrying out promotion and information activities.The applicant will use MPG visualisation.The export product will be innovative pharmaceutical products based on activated carbon in tablets, capsules and syrup.EXIM PHARMA will participate as an issuer for the following events:1.Middle East Pharma Cold Chain Congress, Dubai, United Arab Emirates 2.CPhl BioPh India, Mumbai, India 3.Vitapfoods Europe, finished Products, Geneva, Switzerland The Group is composed of smart specialisation products:HEALTHY KIS 3.MANUFACTURE OF MEDICINAL PRODUCTS II.GENERIC AND INNOVATIVE PRODUCTS, FOOD SUPPLEMENTS, FOODS FOR PARTICULAR NUTRITIONAL USES 1.Development of technologies for the production of ‘innovative’ generic products and innovative medical devices, food supplements, foods for particular nutritional uses. (English) | |||
| Property / summary: Reference_reference_programme_aids:SA.42799 (2015/X): _aid_public: _Article 19 The project will be implemented under BPP BIOTECHNOLOGY AND pharmaceuticatics for the prospective market:INDIA AND ZEA.The activities will be carried out in the UAE, India and SWITZERLAND within the scope of the project. promotional activities will be implemented through the purchase of an advice service on the internationalisation of entrepreneurs, training on the internationalisation of entrepreneurs, staff missions at fairs and missions.The applicant will implement the project by booking exhibition spaces at trade fairs, making registration fees and registration fees in the market catalogue, organising exhibition stands at fairs and carrying out promotion and information activities.The applicant will use MPG visualisation.The export product will be innovative pharmaceutical products based on activated carbon in tablets, capsules and syrup.EXIM PHARMA will participate as an issuer for the following events:1.Middle East Pharma Cold Chain Congress, Dubai, United Arab Emirates 2.CPhl BioPh India, Mumbai, India 3.Vitapfoods Europe, finished Products, Geneva, Switzerland The Group is composed of smart specialisation products:HEALTHY KIS 3.MANUFACTURE OF MEDICINAL PRODUCTS II.GENERIC AND INNOVATIVE PRODUCTS, FOOD SUPPLEMENTS, FOODS FOR PARTICULAR NUTRITIONAL USES 1.Development of technologies for the production of ‘innovative’ generic products and innovative medical devices, food supplements, foods for particular nutritional uses. (English) / rank | |||
Normal rank | |||
Revision as of 09:28, 4 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The development of the undertaking of EXIM by promotion on international markets. |
Project in Poland financed by DG Regio |
Statements
314,800.0 zloty
0 references
393,500.0 zloty
0 references
80.0 percent
0 references
30 April 2018
0 references
31 December 2019
0 references
EXIM PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
0 references
Numer_referencyjny_programu_pomocowego: SA.42799(2015/X) Przeznaczenie_pomocy_publicznej:_art.19 Projekt realizowany będzie w ramach BPP BIOTECHNOLOGIA I FARMACEUTYKA Wybrany rynek perspektywiczny: INDIE I ZEA. Działania prowadzone będą w ZEA, INDIACH I SZWAJCARII W zakresie projektu realizowane będą działania działania promocyjne, poprzez zakup usługi doradczej dotyczącej umiędzynarodowienia przedsiębiorcy, szkolenia w zakresie umiędzynarodowienia przedsiębiorcy, podróże służbowe pracowników podczas targów i misji. Wnioskodawca będzie realizował projekt rezerwując miejsca wystawowe na targach, dokonując opłat rejestracyjnych i wpisów do katalogu targowego, organizując stoiska wystawowe na targach oraz realizując działania promocyjno-informacyjne. Wnioskodawca będzie stosować wizualizację MPG. Produktem eksportowym będą innowacyjne wyroby farmaceutyczne produkowane na bazie węgla aktywowanego w tabletkach, kapsułkach i syropie. EXIM PHARMA weźmie udział jako wystawca w następujących imprezach: 1. Middle East Pharma Cold Chain Congress, Dubaj, Zjednoczone Emiraty Arabskie 2. CPhl BioPh India, Mumbai, Indie 3. Vitafoods Europe, Finished Products, Genewa, Szwajcaria W skład grupy wchodzą produkty z obszaru inteligentnych specjalizacji: ZDROWE SPOŁECZEŃSTWO KIS 3. WYTWARZANIE PRODUKTÓW LECZNICZYCH II. INNOWACYJNE PRODUKTY GENERYCZNE ORAZ INNOWACYJNE WYROBY MEDYCZNE, SUPLEMENTY DIETY, ŚRODKI SPOŻYWCZE SPECJALNEGO PRZEZNACZENIA ŻYWIENIOWEGO 1. Opracowanie technologii wytwarzania „innowacyjnych” produktów generycznych oraz innowacyjnych wyrobów medycznych, suplementów diety, środków spożywczych specjalnego przeznaczenia żywieniowego. (Polish)
0 references
Reference_reference_programme_aids:SA.42799 (2015/X): _aid_public: _Article 19 The project will be implemented under BPP BIOTECHNOLOGY AND pharmaceuticatics for the prospective market:INDIA AND ZEA.The activities will be carried out in the UAE, India and SWITZERLAND within the scope of the project. promotional activities will be implemented through the purchase of an advice service on the internationalisation of entrepreneurs, training on the internationalisation of entrepreneurs, staff missions at fairs and missions.The applicant will implement the project by booking exhibition spaces at trade fairs, making registration fees and registration fees in the market catalogue, organising exhibition stands at fairs and carrying out promotion and information activities.The applicant will use MPG visualisation.The export product will be innovative pharmaceutical products based on activated carbon in tablets, capsules and syrup.EXIM PHARMA will participate as an issuer for the following events:1.Middle East Pharma Cold Chain Congress, Dubai, United Arab Emirates 2.CPhl BioPh India, Mumbai, India 3.Vitapfoods Europe, finished Products, Geneva, Switzerland The Group is composed of smart specialisation products:HEALTHY KIS 3.MANUFACTURE OF MEDICINAL PRODUCTS II.GENERIC AND INNOVATIVE PRODUCTS, FOOD SUPPLEMENTS, FOODS FOR PARTICULAR NUTRITIONAL USES 1.Development of technologies for the production of ‘innovative’ generic products and innovative medical devices, food supplements, foods for particular nutritional uses. (English)
0 references
Identifiers
POIR.03.03.03-14-0011/18
0 references